Procter & Gamble Health Current Share Price | Procter & Gamble Health Stock Screener
PGHL
Pharmaceuticals
Procter & Gamble Health Current Stock Price Today
Live Share Price NSE
₹5503.50
▲
69.00 (1.27%)
Live Share Price BSE
₹5502.00
▲
67.05 (1.23%)
As of September 18, 2026, the live Procter & Gamble Health share price (NSE: PGHL) is ₹5,503.50 on NSE and ₹5,502.00 on BSE, up 1.27% from the previous close, with shares trading between ₹5,434.00 and ₹5,529.00 in today's trading session, and a 52-week range of ₹4,778.60–₹6,918.50.
Browse PGHL financial statements to support your investment research.
Use the Procter & Gamble Health stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Procter & Gamble Health Market Cap
₹9,063.26 Cr.
PGHL P/E Ratio (TTM)
25.23
Procter & Gamble Health P/B Ratio
17.17
EPS (TTM)
₹197.00
Dividend Yield
3.78%
Debt to Equity
0.02
PGHL 52 Week High
₹6918.50
Procter & Gamble Health 52 Week Low
₹4778.60
Operating Margin
33.00%
Profit Margin
24.09%
PGHL Revenue (TTM)
₹1,482.00
EBITDA
₹515.00
Net Income
₹357.00
Total Assets
₹841.00
Total Equity
₹525.00
Procter & Gamble Health Current Share Price Chart
Track the current Procter & Gamble Health share price and stock price with an interactive chart. Analyse PGHL price trends, trading volume, historical performance, and volatility across different timeframes — the complete Procter & Gamble Health stock quote in one place.
Procter & Gamble Health Company Profile - Fundamental Screener
Screen Procter & Gamble Health company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for PGHL shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE199A01012
Procter & Gamble Health Balance Sheet Screener
Screen PGHL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 841 | 794 | 794 | 1,101 | 888 | 986 | 1,176 | 1,760 | 991 | 879 |
| Current Assets | 556 | 526 | 524 | 796 | 608 | 727 | 954 | 1,534 | 752 | 636 |
| Fixed Assets | 102 | 116 | 129 | 144 | 112 | 104 | 101 | 104 | 115 | 111 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 62 | 42 | 37 | 46 | 40 | 44 | 42 | 27 | 33 | 29 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 525 | 537 | 538 | 751 | 617 | 704 | 906 | 1,540 | 733 | 664 |
| Share Capital | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 |
| Reserves & Surplus | 508 | 520 | 522 | 734 | 600 | 687 | 890 | 1,524 | 717 | 647 |
Procter & Gamble Health Income Statement Screener - Profit & Revenue Analysis
Screen Procter & Gamble Health income statement and profit fundamentals.
Analyze PGHL quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Procter & Gamble Health share price evaluation.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,482 | 1,425 | 945 | 1,167 | 1,248 | 1,128 | 1,027 | 1,425 | 873 | 722 | 1,017 | 963 |
| Expenses | 967 | 951 | 616 | 845 | 905 | 847 | 763 | 1,041 | 701 | 621 | 877 | 856 |
| EBITDA | 515 | 474 | 329 | 322 | 343 | 281 | 264 | 384 | 173 | 101 | 140 | 107 |
| Operating Profit % | 33.00% | 32.00% | 34.00% | 27.00% | 26.00% | 24.00% | 24.00% | 23.00% | 17.00% | 11.00% | 12.00% | 9.00% |
| Depreciation | 24 | 24 | 17 | 27 | 28 | 27 | 30 | 30 | 21 | 19 | 25 | 23 |
| Interest | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 490 | 450 | 312 | 273 | 314 | 253 | 233 | 355 | 158 | 99 | 115 | 83 |
| Tax | 127 | 123 | 77 | 72 | 85 | 61 | 57 | 101 | 56 | 38 | 36 | 30 |
| Net Profit | 357 | 327 | 234 | 201 | 230 | 193 | 177 | 254 | 102 | 61 | 79 | 54 |
| EPS | 215.00 | 197.00 | 141.00 | 121.00 | 138.00 | 116.00 | 107.00 | 153.00 | 505.27 | 56.60 | 47.70 | 32.30 |
Procter & Gamble Health Cash Flow Screener - Liquidity Fundamentals
Screen PGHL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 338 | 169 | 228 | 236 | 170 | 247 | 235 | -130 | 54 | 107 |
| Investing Activities | 1 | 10 | -7 | -22 | -26 | -32 | 165 | 1,270 | -48 | -75 |
| Financing Activities | -344 | -235 | -418 | -99 | -289 | -387 | -883 | -30 | -22 | -15 |
| Net Cash Flow | -5 | -57 | -197 | 116 | -145 | -172 | -483 | 1,109 | -16 | 17 |
Procter & Gamble Health Shareholding Pattern Screener
See Procter & Gamble Health shareholding pattern with promoter, FII, and DII holdings.
Check Procter & Gamble Health promoter holding and ownership changes for PGHL on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% | 51.82% |
| FII Holding | 6.20% | 6.33% | 6.87% | 6.99% | 7.24% | 6.97% | 6.24% | 6.40% |
| DII Holding | 13.68% | 12.44% | 14.21% | 14.16% | 13.91% | 13.84% | 13.73% | 14.55% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 23.17% | 23.56% | 21.90% | 21.89% | 22.15% | 22.43% | 22.61% | 21.82% |
| Other Holding | 5.14% | 5.85% | 5.21% | 5.14% | 4.89% | 4.94% | 5.60% | 5.41% |
| Shareholder Count | 50,883 | 49,056 | 53,993 | 52,478 | 50,006 | 49,302 | 56,778 | 55,923 |
Procter & Gamble Health Share Dividend Screener - Share Yield Analysis
Check Procter & Gamble Health dividend history with payout and yield data.
View Procter & Gamble Health dividend details including ex-dates and amounts for PGHL stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹205.00 | 3.79% |
| 2025-March | ₹125.00 | 2.60% |
| 2024-March | ₹260.00 | 5.05% |
| 2023-March | ₹95.00 | 2.02% |
| 2022-March | ₹52.50 | 1.12% |
| 2021-March | ₹130.00 | 3.25% |
| 2020-March | ₹230.00 | 3.71% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹440.00 | 11.91% |
| 2017-March | ₹15.00 | 1.00% |
Procter & Gamble Health Stock Index Membership
See which indices include Procter & Gamble Health stock.
Check PGHL index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX BSE500
BSE INDEX MSL400
BSE INDEX SML250
BSE INDEX SMLCAP
Procter & Gamble Health Market Events Screener - Corporate Actions
Get Procter & Gamble Health corporate actions including splits, bonuses, and buybacks.
Check Procter & Gamble Health stock events that may affect PGHL share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-03 | 2026-09-03 | Annual General Meeting | NA | -0.74% |
| 2026-08-27 | 2026-08-27 | Dividend | ₹ 45.00 /share | 0.78% |
| 2026-08-06 | 2026-08-06 | Quarterly Result Announcement | NA | 3.50% |
| 2026-05-26 | 2026-05-26 | Quarterly Result Announcement | NA | 15.83% |
| 2026-02-12 | 2026-02-12 | Dividend | ₹ 50.00 /share | 4.56% |
| 2026-02-12 | 2026-02-12 | Dividend | ₹ 110.00 /share | 4.56% |
| 2026-02-06 | 2026-02-06 | Quarterly Result Announcement | NA | -6.98% |
| 2025-11-05 | 2025-11-05 | Quarterly Result Announcement | NA | -3.34% |
| 2025-08-29 | 2025-08-29 | Annual General Meeting | NA | 1.83% |
| 2025-08-22 | 2025-08-22 | Dividend | ₹ 45.00 /share | 10.63% |
| 2025-08-01 | 2025-08-01 | Quarterly Result Announcement | NA | 0.33% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 5.91% |
| 2025-02-21 | 2025-02-21 | Dividend | ₹ 80.00 /share | 1.63% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -3.43% |
| 2024-12-05 | 2024-12-05 | Annual General Meeting | NA | -0.50% |
Procter & Gamble Health Competitors Screener - Peer Comparison
Screen PGHL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 444,717 | 36.34 | 61,674 | 12.69% | 11,565 | 38.94 |
| Divis Laboratories | 243,116 | 83.41 | 11,067 | 13.95% | 2,568 | 57.81 |
| Torrent Pharmaceuticals | 183,052 | 85.57 | 13,886 | 20.34% | 2,138 | 42.03 |
| Zydus Life Science | 111,440 | 23.87 | 27,658 | 17.64% | 5,026 | 43.86 |
| Cipla | 109,705 | 32.76 | 29,045 | 2.24% | 3,870 | 35.04 |
| Laurus Labs | 102,870 | 95.29 | 6,868 | 22.01% | 890 | 56.63 |
| Dr Reddys Laboratories | 95,152 | 30.15 | 35,059 | 3.90% | 4,158 | 39.81 |
| Aurobindo Pharma | 94,535 | 25.82 | 34,145 | 5.56% | 3,503 | 49.75 |
| Lupin | 93,504 | 16.93 | 29,039 | 26.75% | 5,356 | 22.87 |
| Mankind Pharma | 92,759 | 45.72 | 14,636 | 14.85% | 1,938 | 34.16 |
Procter & Gamble Health Company Announcements - News Screener
Screen PGHL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-09-04 | Re-Appointment Of Mr. S. Madhavan As Independent Director Of The Company. | - |
| 2026-09-04 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-09-03 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-08-12 | 59Th Annual General Meeting Of The Company | - |
| 2026-08-12 | Business Responsibility and Sustainability Reporting (BRSR) | - |
| 2026-08-12 | Reg. 34 (1) Annual Report. | - |
| 2026-08-12 | Notice Calling The 59Th Annual General Meeting Of The Company. | - |
| 2026-08-10 | Record Date For Purpose Of Dividend | - |
| 2026-08-06 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-08-06 | Unaudited Financial Results For The Quarter Ended June 30 2026 | - |
| 2026-08-06 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2026-07-15 | Update Regarding CompanyS Annual General Meeting For The Financial Year 2025-26 And Record Date | - |
| 2026-07-03 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-26 | Communication In Respect Of Deduction Of Tax At Source (TDS) On The Amount Of Dividend Income From Procter & Gamble Health Limited (The Company) | - |
| 2026-06-26 | Closure of Trading Window | - |
| 2026-06-26 | Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On August 6 2026 | - |
| 2026-06-25 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-06-18 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-06-18 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-06-04 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |